Development of complement C5aR1 antagonists for the treatment of motor neuron disease (2016–2017)

Grant type:
UQ Collaboration and Industry Engagement Fund - FirstLink
Researchers:
  • Senior Lecturer in Drug Development
    School of Biomedical Sciences
    Faculty of Medicine
    Affiliate ARC Future Fellow
    Institute for Molecular Bioscience
  • Professor
    School of Biomedical Sciences
    Faculty of Medicine
Funded by:
University of Queensland